Meeting Details

The Extra-Ordinary General Meeting of Krishna Institute of Medical Sciences Limited was held on Thursday, 9 July 2026 at 04:00 P.M. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM). The meeting was conducted without physical presence of members at a deemed venue located at the Registered Office of the Company: D. No. 1-8-31/1, Minister Road, Secunderabad – 500 003, Telangana, India.

The meeting was conducted in compliance with the Companies Act, 2013, MCA Circulars (General Circular Nos. 14/2020 dated 8 April 2020 and 17/2020 dated 13 April 2020), SEBI circulars, and Secretarial Standard-2 issued by ICSI.

Attendance

57 Members attended the meeting through VC/OAVM, constituting the requisite quorum.

Directors Present (Through VC/OAVM):

  • Mr. Adwik Bollineni - Non-Executive Director
  • Dr. Saumen Chakraborty - Independent Director
  • Mr. K. Ratna Kishore - Independent Director
  • Mr. J V Ramudu - Independent Director
  • Ms. Y. Prameela Rani - Independent Director
  • Mr. Suresh N Patel - Independent Director

Directors and KMP Present in Person:

  • Dr. Bhaskara Rao Bollineni - Chairman and Managing Director
  • Ms. Anitha Dandamudi - Whole time Director
  • Mr. Sachin Salvi - Chief Financial Officer
  • Ms. Nagajayanthi J. R - Company Secretary

Representatives of Statutory Auditors (S.R. Batliboi & Associates LLP) and Secretarial Auditor were also present through VC/OAVM.

Chairperson of Meeting

Ms. Anitha Dandamudi presided as Chairperson as Dr. Bhaskara Rao Bollineni, Dr. Abhinay Bollineni, and Mr. Adwik Bollineni were interested in the business items.

Business Transacted

The following resolutions set out in the EGM Notice dated 15 June 2026 and Corrigendum dated 4 July 2026 were duly transacted:

Item 1: Special Resolution

Issue of 77,02,182 (Seventy-Seven Lakh Two Thousand One Hundred and Eighty-Two) Warrants, each fully convertible into or exchangeable for 1 (One) fully paid-up equity share of ₹2/- (Indian Rupees Two) each, on a preferential basis to:

  • Dr. Abhinay Bollineni (Promoter)
  • Mr. Adwik Bollineni (Promoter)
  • Bharas Ventures LLP (a Promoter Group entity)

Total consideration: ₹1,540.44 crore (based on issue price of ₹2,000 per warrant)

Item 2: Ordinary Resolution

Change of designation of Mr. Adwik Bollineni (DIN: 06549059) from Non-Executive Director to Executive Director of the Company for a period of 5 (Five) years with effect from 15 May 2026.

Voting Process

The Company engaged MUFG Intime India Private Limited (formerly Link Intime India Private Limited) for providing remote e-voting and e-voting during the EGM. Remote e-voting was open from Monday, 6 July 2026 at 9:00 A.M. (IST) to Wednesday, 8 July 2026 at 5:00 P.M. (IST). Members present at the meeting who had not cast votes through remote e-voting were able to cast votes during the meeting.

M/s. IKR & Associates, Practicing Company Secretaries, were appointed as Scrutinizer to scrutinize the voting process. Mr. I. Krishna Rao, Proprietor, was present virtually throughout the meeting.

Additional Information

The voting results and Consolidated Scrutinizer's Report will be submitted to BSE Limited and National Stock Exchange of India Limited within statutory timelines and will be uploaded on the Company's website (https://www.kimshospitals.com/investors/) and MUFG Intime India Private Limited's website (https://instavote.linkintime.co.in/).

The meeting included a session for shareholder queries and views on the resolutions, with the Chairperson providing responses. The meeting concluded at 4:50 P.M. (IST).